J&J Medical Connect
RISPERDAL®

(risperidone)

This information is intended for US patients and caregivers to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended to promote the use of our products, nor to provide medical advice.

RISPERDAL ORAL SOLUTION – Instructions for Use

Last Updated: 01/29/2025

SUMMARY

  • The RISPERDAL® Prescribing Information was updated in March 2022 including revised “Instructions for Use” for RISPERDALOral Solution.1
  • Please refer to the attached FDA-approved patient labeling (Instructions for Use) for RISPERDAL Oral Solution.2
  • The instructions for use are available in English and Spanish.

References

1 RISPERDAL (risperidone) [Prescribing Information]. Titusville, NJ: Janssen Pharmaceuticals, Inc; https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/RISPERDAL-pi.pdf.  
2 RISPERDAL Oral Solution - Instructions for Use [Prescribing Information]. Titusville, NJ: Janssen Pharmaceuticals, Inc; https://imedicalknowledge.veevavault.com/ui/approved_viewer?token=7994-59b1d102-e45b-4a21-82b6-8c25e18a741a.